- Our Company
- CMF & Orthopedics
- Biomedical Manufacturing
- News & Events
OPM Press Releases
Grand Opening of Oxford Performance Materials' Manufacturing and Office Facility in Japan Set for July 16th
July 10th, 2019
OPM Japan Subsidiary is partnership with JSR Corporation to advance OPM’s OsteoFab® 3D Printed Implant and OXPEKK® Biomedical Materials Technology Platforms throughout Asia.
June 20th, 2019
Research Study by McGill University1 Definitively Establishes Suitability of 3D Printed PEKK Scaffolds as Integral Component for Regenerating Critical-sized Bone Defects
Oxford Performance Materials’ Partner RTI Surgical Wins 2018 Orthopedics This Week Spine Technology Award
October 9th, 2018
OPM is Exclusive Supplier of OsteoFab® Additive Manufacturing Solution Used in Manufacturing of RTI’s TETRAfuse® 3D Technology
OPM Asia Announces Engagement of Curt Jennewine to Lead Commercial Development of Business throughout Asia
June 14th, 2018
OPM Asia, a partnership between Oxford Performance Materials, Inc. (OPM) and Tokyo-based JSR Corporation (JSR), today announced the engagement of Curt Jennewine to lead the commercial development of its poly-ether-ketone-ketone (PEKK)-based biomedical and dental materials businesses throughout Asia.
Oxford Performance Materials and JSR Corporation Announce Partnership to Advance OPM Technology Platform Throughout Asia
May 14th, 2018
South Windsor, CT and Tokyo, Japan, May 14, 2018 - Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM®), and Tokyo-based JSR Corporation (JSR), a leading materials supplier in a variety of technology driven markets, today announced a partnership to advance OPM’s poly-ether-ketone-ketone (PEKK)-based 3D-printed orthopedic devices and biomedical & dental materials businesses throughout Asia.
April 11th, 2018
SOUTH WINDSOR, Conn., April 11, 2018 -- Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced the launch of OXPEKK®-SC (Solution Casting).
April 2nd, 2018
South Windsor, CT, April 2, 2018 - Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced the launch of OXPEKK®-LTS (Low Temperature Synthesis).
March 21st, 2018
SOUTH WINDSOR, Conn., March 20, 2018 Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced that the Company has been granted Accreditation of Foreign Medical Device Manufacturer by the Japanese Ministry of Health, Labour and Welfare. This accreditation lays the groundwork for OPM’s expansion into the rapidly growing Asian healthcare market.
Oxford Performance Materials Sells Aerospace & Defense Business to Strategic Investor Hexcel Corporation
December 8th, 2017
Transaction Follows Successful High-Profile Adoption by Aerospace Customers and Paves Way for Future Growth of OPM’s Biomedical, Industrial and Materials Businesses
South Windsor, CT, December 8, 2017 - Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced that it has finalized terms for sale of its Aerospace & Defense business to advanced composites leader Hexcel Corporation. The transaction allows OPM to monetize its success as an early provider of qualified 3D printed OXFAB® structures in commercial aerospace, space and defense and advance the company’s position as a biomedical OEM, industrial parts manufacturer and developer of a range of PEKK-based materials technology.
Antibacterial Benefits of PEKK for Orthopedic Applications Detailed in Study of 3D-Printed OsteoFab® Structures
December 5th, 2017
The antibacterial attributes of 3D printed PEKK are significant, since they address two areas of growing concern in medicine. “Orthopedic implant infections have been steadily increasing while, at the same time, antibiotics developed to kill such bacteria have proven less and less effective with every passing day,” according to the researchers. “It is clear that new approaches that do not rely on the use of antibiotics are needed to decrease medical device infections.” As a result, the antibacterial properties detailed in this new study that apply to OsteoFab devices will provide another important layer of differentiation for the performance of OPM medical devices in the marketplace.
There are no articles posted this month.